The Pennsylvania Commission on Crime and Delinquency (PCCD) is now accepting applications for its 2026 Medication-Assisted Substance Use Treatment Grant Program.
Donor Name: Pennsylvania Commission on Crime and Delinquency (PCCD)
State: Pennsylvania
County: All Counties
Type of Grant: Grant
Deadline: 04/16/2026
Size of the Grant: $100,000 to $500,000
Grant Duration: 2 Years
Details:
The primary purpose of this funding is to support counties seeking to increase opportunities to provide Medication-Assisted Treatment (MAT), in combination with comprehensive substance use disorder treatment, to eligible offenders who meet the clinical criteria for an opioid use disorder or an alcohol use disorder, as determined by a physician, while incarcerated and upon release from a county jail. For purposes of this funding announcement, the term “Medication-Assisted Treatment” means the use of United States Food and Drug Administration-approved medications (buprenorphine, methadone, and naltrexone/Vivitrol), together with nonmedication treatment, as clinically indicated, to treat substance use disorders, including opioid use disorders and alcohol use disorders. Administration of these medications along with comprehensive substance use disorder treatment will allow newly released participants to focus on immediate reentry needs.
Funding Information
Approximately $7.7 million in state Act 80 funds is being announced to support this initiative. PCCD expects to fund 61 grants with budgets not to exceed $250,000 over a 24- month project period.
Eligible Activities
Funds for the proposed program may be used for, but are not limited to, the following eligible activities and expenses:
- Implementation and/or expansion of a county jail-based MAT program through a contracted entity, provider(s), or organization(s). In addition to the requirements for an entity, provider(s), or organization(s) set forth in the Eligible Applicants section, the following required protocols must be established for all programs:
- Programs must provide ongoing education regarding United States Food and Drug Administration-approved medications (buprenorphine, methadone, and naltrexone/Vivitrol) and refer interested individuals to relevant staff for eligibility determination.
- Programs must order labs (ALT, AST, BUN, and Creatinine) to ensure individuals are not experiencing liver failure and do not have acute hepatitis or other liver conditions.
- Prior to medication administration, programs must provide an instant drug screen and an instant pregnancy test (for females) and administer medications only for participants whose results are negative.
- Additionally, the following protocols are strongly encouraged for all programs:
- Programs should continue to provide MAT to individuals with a valid prescription and induct individuals on MAT who meet the clinical criteria for an opioid use disorder or an alcohol use disorder, as determined by a physician.
- If utilizing naltrexone/Vivitrol, programs are encouraged to provide multiple injections prior to release. Note: all injections given inside the jail must be paid for with grant funding.
- Programs should assist participants with applications for Medicaid benefits, if eligible.
- Programs should contract with a licensed drug and alcohol provider within the community to deliver treatment services.
- Programs should work with participants to schedule all necessary community-based appointments (e.g., counseling services, monthly injections, etc.) prior to release.
- Cost of United States Food and Drug Administration-approved medications for participants in county jails.
- Evidence-based psychosocial treatment programming for justice-involved populations.
- County jail personnel costs to assist in administering the program.
- Travel expenses for staff to attend required training and technical assistance activities.
Eligibility Criteria
Eligibility for these funds is open to all counties with a county jail seeking to establish or expand a jail-based substance use treatment program that supports individuals transitioning from a county jail to the community or individuals who are sentenced to serve probation with restrictive conditions sentences. Eligible applicants are required to contract with an entity, provider(s), or organization(s) that shall:
- Provide an appropriate individual assessment prior to reentry into the community and determine if the individual is an appropriate candidate for participation in this program;
- Create an individualized program for each appropriate candidate;
- Provide access to and administer United States Food and Drug Administration approved medications (buprenorphine, methadone, and naltrexone/Vivitrol);
- Provide clinically appropriate inpatient or outpatient services determined as necessary to support treatment plans;
- Cooperate with the county probation and parole offices as to the use of any drug by eligible participants; and
- Create a discharge plan for everyone
For more information, visit PCCD.
